Tag Archives: Invokana

Featured Stories

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

Bronx Teenager Killed in Hit-and-Run, Second Teen Injured

A Port Jefferson Station man was killed on Wednesday in a single-vehicle crash on the Northern State Pkwy in Dix Hills west of Exit 42. He was driving a Nissan Altima.

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

FDA Questions Device Makers about Duodenoscope Cleaning Procedures

Following Deadly Outbreaks, FDA Questions Device Makers about Duodenoscope Cleaning Procedures

In light of a recent outbreak linked to contaminated duodenoscopes, the U.S. Food and Drug Administration (FDA) is questioning manufacturers about their methods for cleaning the devices, the New York Times reports. The specialized scopes, which have been linked to several outbreaks in recent years, most recently infected seven patients ...

Read More

Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J

Invokana’s Link to Ketoacidosis Hidden by Janssen and J&J

A Florida woman alleges, in a recent lawsuit brought against the makers of Invokana–Janssen Pharmaceuticals, and its parent company Johnson & Johnson (J&J)–, that the drug makers neglected to issue a proper warning about the connection between Invokana and ketoacidosis, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , , , , , , |

Janssen Failed to Warn of Ketoacidosis Risk with Invokana Diabetes Drug, Suit Alleges

Janssen Failed to Warn of Issue with Invokana Diabetes Drug

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is accused of failing to warn about the risk of ketoacidosis with its type 2 diabetes drug Invokana. Diabetic ketoacidosis is a serious condition caused by the build up of ketone bodies, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , , |

Lawsuit Alleges Invokana Responsible for Diabetic Ketoacidosis Injury

Invokana-Diabetic-Ketoacidosis

A lawsuit filed against Johnson & Johnson and its subsidiary, Janssen, alleges that the Janssen diabetes medication, Invokana, causes patients to develop diabetic ketoacidosis. The lawsuit was filed in the Court of Common Pleas, Philadelphia County, and includes allegations that … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals | Tagged , , , , |

Invokana Increases Risk of Bone Fractures, FDA Warns

Invokana Increases Risk of Bone Fractures

The Food and Drug Administration (FDA) issued a safety announcement in September warning patients and health care providers of an increased risk of bone fractures in patients taking the type 2 diabetes drugs Invokana and Invokamet (canagliflozin). The FDA deemed … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals | Tagged , , , , |

FDA Warns about Bone Fracture Risks with Invokana

FDA Warns about Bone Fracture Risks with Invokana

The Food and Drug Administration (FDA) has updated the warning label of the type 2 diabetes drug canagliflozin (Invokana, Invokamet) to warn about the increased risk of bone fractures and reduced bone mineral density for those taking canagliflozin. This warning … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , |

FDA Warns of Increased Bone Fracture Risk for Diabetes Patients Taking Invokana and Invokamet

FDA Warns of Bone Fracture Risk for Diabetes Drugs

Last week, the Food and Drug Administration (FDA) issued a safety communication providing information on bone fracture risk and decreased bone density in patients taking the diabetes drugs Invokana and Invokamet (canagliflozin). The FDA has strengthened the warning for the … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.